Wilmington PharmaTech (“Wilmington”), a leading U.S.-based research, development, and manufacturing organization (CRDMO) ...
In this interview, NewsMed talks to Dr. James Mencel's Guidance about Scaling Up API Processes. Could you introduce yourself and your experience in the pharmaceutical industry? I obtained a B.S. in ...
Arul Ramadurai, CCO, Axplora, discusses the company’s investment in expanding its HPAPI development and manufacturing ...
BARCELONA, SPAIN – February 26, 2026 – ESTEVE CDMO, the global pure-play CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, today announced that it had commenced a ...
qualified companies can utilize one or more of three established pharmaceutical manufacturing plants on the campus under a ...
TEDA TIANJIN, China--(BUSINESS WIRE)--Asymchem Laboratories (Tianjin) Co., Ltd. (Stock Code 002821.SZ/6821.HK) announced today that it will operate the former Pfizer U.K. small molecule API pilot ...
Raubling, Germany-based Axplora, which focuses on small-molecule API manufacturing reports that its total investments initiated across its global network in 2025 will exceed €100 million ($115.6 ...
Agno Pharma Acquires Actylis’s CDMO Manufacturing Asset, the Legacy Cascade Chemistry Business based in Eugene, Oregon, Strengthening Agno’s US cGMP API Development and Manufacturing Capabilities Agno ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results